Studies have shown that FTO is overexpressed in gastric cancer and that its demethylase activity upregulates CDKAL1, which promotes cell proliferation and mitochondrial fusion, thereby increasing the resistance of gastric cancer to chemotherapy with 5-Fu (Liu et al., 2023). The gene discussed is MBD2; the disease is gastric cancer.